Timur Sarac, MD

Surgeon:

Yes

Treats:

Adults Only

Timur Sarac, MD, is a Staff Vascular Surgeon in Cleveland Clinic's Department of Vascular Surgery. He is board-certified in vascular and general surgery. Dr. Sarac’s specialty interests are minimally invasive vascular surgery, endovascular stents, aortic aneurysm stents/repair, carotid artery stent/surgery, thoraco-abdominal aortic repair/reconstruction, thoracic aortic aneurysm repair, abdominal aortic aneurysm repair, re-operative surgery and peripheral artery/vein repair/bypass surgery.

A native of Buffalo, N.Y., Dr. Sarac did his undergraduate work at the University of Rochester and Canisius College in Buffalo, from which he graduated cum laude with degrees in biology and history. He received his medical degree, graduating summa cum laude, from the State University of New York at Buffalo School of Medicine. He continued there to pursue additional training in surgical oncology and tumor immunology, receiving the Buffalo Surgical Society Award for Highest Academic Achievements. Dr. Sarac took his surgical residency at the University of Rochester, becoming Chief Resident in Surgery. He then spent two years there as a Research Fellow. He received a fellowship in vascular surgery from the University of Florida College of Medicine in Gainesville and a fellowship in endovascular surgery from the Texas Tech University in Lubbock.

Dr. Sarac holds an academic appointment as Associate Professor at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Prior to joining Cleveland Clinic in 1999, Dr. Sarac was a Vascular Surgeon at Walter Reed Army Medical Center.

In 2003, Dr. Sarac served with the United States Army in Operation Iraqi Freedom, receiving the Enduring Freedom Achievement Medal.

Dr. Sarac has conducted many research studies on his clinical interests in preventing and treating vascular and coronary disease. Much or his research is grant supported. He is Principal Investigator in the Pivotal Trial. He is also a researcher in the VALOR trial and the CREST Carotid Stent Trial, among others. He has received ten patents for his development of methods and apparatuses for repair of aneurysms and blockages and for his development of prosthetic valves. He also is the inventor of a tissue lined stent.

Dr. Sarac has presented his research and clinical experience at national medical meetings and symposia, including before the American College of Surgeons and the International Society for Endovascular Therapy, among others.

He serves as editorial reviewer for the Journal of Vascular Surgery, the Journal of Endovascular Therapy, Vascular Surgeon and Vascular Medicine. He has authored or co-authored eight chapters in medical textbooks on his specialty interests and nearly 45 articles in leading peer-reviewed medical journals.

Dr. Sarac is a Fellow of the American College of Surgeons. He is a member of the American Association for Vascular Surgery, the Society for Vascular Surgery, the International Society for Vascular Surgery, the Midwestern Vascular Society and the Cleveland Vascular Society.

Fellowship - University of Florida College of Medicine

Gainesville, FL USA
1999

Residency - University of Rochester-Strong Memorial Hospital

General Surgery
Rochester, NY USA
1997

Internship - University of Rochester School of Medicine and Dentistry

General Surgery
Rochester, NY USA
1991

Medical School - State University of New York at Buffalo School of Medicine and Biomedical Scienc

Buffalo, NY USA
1990

Graduate - State University of New York at Buffalo Affiliated Hospitals

Buffalo, NY USA
1986

Undergraduate - Canisius College of Buffalo

Buffalo, NY USA
1985

• Surgery- Vascular Surgery

Aortic aneurysms, carotid artery disease, cerebrovascular disease, peripheral artery disease, aorta surgery, carotid endarterectomy, carotid stenting, dialysis access procedures, stents for peripheral vascular disease, surgery for peripheral arterial disease (PAD), aortic aneurysm open repair and endovascular repair

• Amputation
• Aneurysm Surgery - Lower Extremities
• Aneurysm Surgery - Upper Extremity
• Angioplasty
• Angioplasty/Stenting for Mesenteric Artery Stenosis
• Angioplasty/Stenting for Renal Artery Stenosis
• Angioplasty/Stenting of PAD
• Angioplasty/Stenting of Subclavian Artery
• Angioplasty/Stenting of Vertebral Artery
• Aorta Graft
• Aorta Surgery
• Aortic Dissection
• Aortofemoral Bypass Grafting
• Atherectomy
• Atherectomy for Peripheral Artery Disease
• Atherosclerosis Surgery
• Carotid Angiography
• Carotid Artery Aneurysm Surgery
• Carotid Endarterectomy
• Carotid Stenting
• Carotid-Subclavian Bypass
• Complex Aorta Surgery
• Diagnostic Angiography
• Dialysis Access Surgery
• Embolization of Arteriovenous Malformations
• Embolization of Carotid Body Tumors
• Endovascular Aorta Treatment - Abdominal
• Endovascular Aorta Treatment - Thoracic
• Endovascular Repair - Vascular Disease
• Endovascular Repair Of Abdominal Aortic Aneurysms
• Endovascular Repair of Renal Artery Aneurysm
• Endovascular Surgery
• First Rib Resection
• High Risk Reoperation Surgery
• Intravascular Ultrasound
• IVC Filter Placement
• Non-invasive Testing for Vascular Disease
• Resection of Congenital Vascular Lesions
• Surgery for Peripheral Arterial Disease (PAD)
• Surgery for Thoracic Aortic Aneurysm
• Surgery for Thoracic Outlet Syndrome
• Thoraco-Abdominal-Aneurysms
• Upper Extremity Surgery
• Vascular Tests
• Vascular Ultrasound
• Venous Angioplasty/Stenting
• Venous Thrombolysis

• Abdominal Aortic Aneurysm
• Aortic Aneurysms
• Carotid Artery Aneurysm
• Carotid Artery Disease
• Carotid Body Tumor
• Iliac Artery Aneurysm
• Infected Grafts
• Renal Artery Aneurysm
• Renal Artery Disease
• Visceral Artery Aneurysms

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/21/2012, Dr. Sarac has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Sarac receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

• PeriTec Biosciences, Ltd.

Royalty Payments. Dr. Sarac receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• PeriTec Biosciences, Ltd.

Equity. Dr. Sarac owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:

• PeriTec Biosciences, Ltd.

Fiduciary Role. Dr. Sarac serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

• PeriTec Biosciences, Ltd.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Sarac may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

• PeriTec Biosciences, Ltd.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

• English